Page 5 - Alto Investors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alto investors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alto Investors Today - Breaking & Trending Today

Chuck Ence Purchases 14,500 Shares of Relmada Therapeutics, Inc. (NASDAQ:RLMD) Stock

Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) insider Chuck Ence bought 14,500 shares of the stock in a transaction dated Tuesday, January 30th. The stock was purchased at an average cost of $3.87 per share, for a total transaction of $56,115.00. Following the acquisition, the insider now owns 25,300 shares of the company’s stock, […] ....

Relmada Therapeutics Inc , Blackrock Inc , Millennium Management , Relmada Therapeutics Company Profile , Renaissance Technologies , Securities Exchange Commission , Relmada Therapeutics , Get Free Report , Chuck Ence , Exchange Commission , Therapeutics Trading Down , Alto Investors , Sigma Investments , Relmada Therapeutics Daily , Nasdaq Rlmd , Insider Trading , Nsider Trades ,

Insmed Incorporated (NASDAQ:INSM) Given Consensus Recommendation of "Buy" by Brokerages

Insmed Incorporated (NASDAQ:INSM – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are currently covering the stock, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have issued a report on the […] ....

United States , Sara Bonstein , Wells Fargo Company , Pricet Rowe Associates Inc , Vanguard Group Inc , Insmed Incorporated , Securities Exchange Commission , Jpmorgan Chase Co , William Blair Investment Management , T Rowe Price Investment Management Inc , Get Free Report , Marketbeat Ratings , Wells Fargo , John Drayton Wise , Exchange Commission , Rowe Price Investment Management , Alto Investors , Blair Investment Management , Get Free , Insmed Daily , Nasdaq Insm ,

United Therapeutics Co. (NASDAQ:UTHR) Position Increased by LSV Asset Management

LSV Asset Management raised its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 1.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 383,068 shares of the biotechnology company’s stock after acquiring an additional 3,700 shares during the […] ....

United States , New Zealand General , New Zealand , Paula Mahon , Christopher Causey , United Therapeutics Company Profile , Morgan Stanley , Exchange Commission , Blackrock Inc , Wells Fargo Company , United Therapeutics Co , Jpmorgan Chase Co , United Therapeutics Corporation , Wellington Management Group , Geode Capital Management , United Therapeutics , Free Report , Street Corp , Management Group , Capital Management , Palo Alto Investors , Alto Investors , Get Free Report , Director Christopher Causey , Therapeutics Corporation , Remunity Pump ,

eHealth (NASDAQ:EHTH) Downgraded by Craig Hallum to "Hold"

Craig Hallum downgraded shares of eHealth (NASDAQ:EHTH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Thursday morning, MarketBeat reports. They currently have $7.00 target price on the financial services provider’s stock. Separately, StockNews.com initiated coverage on eHealth in a report on Thursday, October 5th. […] ....

United States , Craig Hallum , Health Inc , Health Stock Performance , Blackrock Inc , Vanguard Group Inc , Health Daily , Free Report , Health Stock , Get Free Report , Alto Investors , State Street Corp , Street Corp , Medicare Supplement , Nasdaq Ehth ,

Knights of Columbus Asset Advisors LLC Acquires 2,360 Shares of Insmed Incorporated (NASDAQ:INSM)

Knights of Columbus Asset Advisors LLC boosted its holdings in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 2.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 113,796 shares of the biopharmaceutical company’s stock after acquiring an […] ....

United States , Roger Adsett , Martina Md Flammer , Wells Fargo Company , William Blair Investment Management , Vanguard Group Inc , Pricet Rowe Associates Inc , Exchange Commission , Insmed Incorporated , Jpmorgan Chase Co , T Rowe Price Investment Management Inc , Securities Exchange Commission , Columbus Asset Advisors , Free Report , Rowe Price Investment Management , Alto Investors , Blair Investment Management , Get Free Report , Visit Holdingschannel , Insmed Daily , Nasdaq Insm , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,